By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ago By Jon Springer - 2 hours 35 min ago By Ad Age ...

We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Maintaining independence and editorial freedom is essential to ...

Merck KGaA and Pfizer have got the fourth checkpoint inhibitor to market after the US regulator approved their avelumab for a rare form of skin cancer. The FDA’s approval of avelumab, marketed ...

The pharmaceutical company posted revenue of $16.66 billion in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $16.55 billion. Merck expects full-year earnings in ...

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. RAHWAY, N.J. – While the Dow Jones Industrial Average has reached all-time highs recently, one of its ...

Shares of Merck & Co. Inc. MRK inched 0.44% higher to $101.17 Thursday, on what proved to be an all-around mixed trading ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

The planned launch of an in-house ad tech platform in 2025 signals Netflix's commitment ... (You can read the full research report on Netflix here >>>) Shares of Merck have gained +0.1% over the ...

Recurrent Energy said Liberty Solar, a 134 megawatt project in Liberty County, about 50 miles northeast of Houston, had ...

Merck and Intel have launched a collaborative academic research initiative in Europe, bringing together eleven institutions ...

Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...